About Helen Cline
Contentious and non-contentious intellectual property.
Helen has a sophisticated understanding of the legal nuances at the interface between patent, medicines regulatory and competition law and uses her knowledge and expertise to develop patent litigation, regulatory and IP commercialisation strategies that take account of the changes and opportunities offered by the Unitary Patent and Unified Patent Court.
Helen is well positioned to support an array of clients as she has been following the setting up of the Unified Patent Court and Unitary Patent and regularly comments on developments. In addition to her expert insight on the UPC system, Helen also has a wealth of experience on all areas of contentious and non-contentious intellectual property law.
Helen publishes regular insights and bulletins that are valued by a wide variety of clients:
“Great summary and overview of the important topics” (Thomas Broeer, Kent Pharma)
“Very high quality report” (Carl Kauffmann, Teva)
“Was extremely interesting and very impressed with the document” (Joe Brice, Head of Government Affairs & Advocacy Bayer)
Contact and connect with Helen Cline
: Connect on Linkedin